These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27003340)

  • 1. Mouse models reveal why Alzheimer's treatment fails.
    Niemeyer JE
    Lab Anim (NY); 2016 Apr; 45(4):125. PubMed ID: 27003340
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models.
    Busche MA; Grienberger C; Keskin AD; Song B; Neumann U; Staufenbiel M; Förstl H; Konnerth A
    Nat Neurosci; 2015 Dec; 18(12):1725-7. PubMed ID: 26551546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
    Schenk DB; Seubert P; Grundman M; Black R
    Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Alzheimer's disease: the beginning of a new era.
    Schenk D
    Curr Alzheimer Res; 2006 Jul; 3(3):177. PubMed ID: 16842091
    [No Abstract]   [Full Text] [Related]  

  • 5. Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part I.
    Agadjanyan MG; Cribbs DH
    CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):1-6. PubMed ID: 19275632
    [No Abstract]   [Full Text] [Related]  

  • 6. Alzheimer disease. Could anti-amyloid-β immunotherapy do more harm than good?
    Wood H
    Nat Rev Neurol; 2016 Jan; 12(1):2. PubMed ID: 26610710
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of beta-amyloid peptide in pathogenesis and immunotherapy of Alzheimer's diseases].
    Yu SN; Liu LY; Liang P
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):113-4. PubMed ID: 15842811
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-peptide immunization: a possible new treatment for Alzheimer disease.
    Schenk DB; Seubert P; Lieberburg I; Wallace J
    Arch Neurol; 2000 Jul; 57(7):934-6. PubMed ID: 10891974
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!
    Lee HG; Zhu X; Nunomura A; Perry G; Smith MA
    Am J Pathol; 2006 Sep; 169(3):738-9. PubMed ID: 16936250
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization for Alzheimer's disease: yet closer to clinical trials.
    Gurwitz D
    Trends Mol Med; 2001 Sep; 7(9):385. PubMed ID: 11530319
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.].
    Araki S
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):21-5. PubMed ID: 20628209
    [No Abstract]   [Full Text] [Related]  

  • 15. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
    Nemirovsky A; Shapiro J; Baron R; Kompaniets A; Monsonego A
    J Neuroimmunol; 2012 Jun; 247(1-2):95-9. PubMed ID: 22498096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta vaccination for Alzheimer's dementia.
    McGeer PL
    Lancet; 2008 Oct; 372(9647):1381; author reply 1381-2. PubMed ID: 18940458
    [No Abstract]   [Full Text] [Related]  

  • 17. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice.
    Paganetti P; Reichwald J; Bleckmann D; Abramowski D; Ammaturo D; Barske C; Danner S; Molinari M; Müller M; Papin S; Rabe S; Schmid P; Staufenbiel M
    Neurobiol Aging; 2013 Dec; 34(12):2866-78. PubMed ID: 23870837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's amyloid immunotherapy: quo vadis?
    Gandy S; Heppner FL
    Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for Alzheimer disease.
    Gouras GK
    MAbs; 2009; 1(2):112-4. PubMed ID: 20061820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
    Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
    J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.